International Patent: APOL1 INHIBITORS AND METHODS OF USE THEREOF

GENEVA, Oct. 1 -- MAZE THERAPEUTICS, INC. filed a patent application (US2026/019127) for “APOL1 INHIBITORS AND METHODS OF USE THEREOF”. With publication no. WO/2026/193408, here are the other details related to the patent application:

Kind: Initial Publication without ISR [A2]

IPC: C07D 471/10

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....